Research by Buchmann et al. (57) has shown that elevated serum levels of inflammatory markers like IL-1β, IL-6, and CRP are linked to muscle weakness in critically ill patients, underscoring inflammation’s significant role in sarcopenia development. This evidence concerns the gene IL6 and sarcopenia.